Repeat ablation for atrial fibrillation using new mapping system
Part of Heart & circulation clinical trials.
This trial tests a new system that maps and treats atrial fibrillation using special energy (pulsed field ablation) during a repeat ablation procedure. It also uses a small implanted monitor to track your heart rhythm before and after the procedure, which may help improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You are diagnosed with atrial fibrillation (AF) and have symptoms, with at least one episode lasting 24 hours or more.
- You have had at least one prior ablation for AF that didn't control it, or no more than two prior ablations limited to the pulmonary veins (the veins from your lungs to your heart).
- You are willing to receive or already have a LUX-Dx heart monitor implanted under your skin to track your rhythm.
- You do not have significant heart conditions like severe valve problems, a very large left atrium, or recent heart events.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This study compares two techniques for treating persistent atrial fibrillation: one uses standard anatomy-based ablation, and the other uses a special mapping system to guide the procedure. It aims to find which method works better for people who have not had prior ablation.
This trial uses a special body-surface mapping technique to guide personalized ablation for persistent atrial fibrillation (afib). It aims to improve outcomes for people with an enlarged left atrium who have not had prior ablation.
This study looks at how a new type of heart procedure, called pulsed field ablation, affects the heart's structure in people with persistent atrial fibrillation. It may help doctors understand if this treatment improves heart function over time.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.